List of insiders holdings for TransMedics Group Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures 2007 General Partner LLC Flagship Ventures Fund 2007 L.P. AFEYAN NOUBAR 10% Owner | 2019-10-31 19:00:29 | 0 2,960,786 | 2,960,786 | Form 4 |
| 2 | ABRAMS CAPITAL MANAGEMENT L.P. ABRAMS CAPITAL MANAGEMENT LLC Abrams Capital Partners II L.P. ABRAMS CAPITAL LLC Abrams David C Riva Capital Partners III L.P. Riva Capital Management III LLC 10% Owner | 2021-02-16 16:01:08 | 1,302,612 0 | 1,302,612 | Form 13G |
| 3 | Hassanein Waleed H President & CEO | 2025-02-26 18:16:52 | 211,609 469,359 | 680,968 | Form 4 |
| 4 | KANIA EDWIN M JR Director | 2025-05-23 18:43:16 | 260,810 46,142 | 306,952 | Form 4 |
| 5 | TOBIN JAMES R Director | 2025-05-23 18:47:12 | 4,059 173,146 | 177,205 | Form 4 |
| 6 | Godhani Rakesh P. Chief Digital Officer | 2021-08-06 17:05:31 | 140,000 0 | 140,000 | Form 4 |
| 7 | Corcoran Nicholas See Remarks | 2025-02-26 18:12:20 | 52,860 0 | 52,860 | Form 4 |
| 8 | Provost Miriam VP, Global Regulatory Affairs | 2023-12-15 17:31:17 | 46,045 0 | 46,045 | Form 4 |
| 9 | Gordon Stephen Chief Financial Officer | 2024-06-05 17:12:25 | 36,716 0 | 36,716 | Form 4 |
| 10 | Khayal Tamer I Chief Commercial Officer | 2025-03-05 16:30:17 | 36,042 0 | 36,042 | Form 4 |
| 11 | Carey John F VP of Operations | 2023-02-03 17:12:57 | 32,550 0 | 32,550 | Form 4 |
| 12 | Sullivan John F VP of Quality & Engineering | 2021-09-01 17:04:44 | 30,045 0 | 30,045 | Form 4 |
| 13 | Hernandez Gerardo Chief Financial Officer | 2025-02-26 18:15:00 | 21,283 0 | 21,283 | Form 4 |
| 14 | DAMME LAURA VP, Clinical Affairs | 2023-02-22 20:00:40 | 14,390 0 | 14,390 | Form 4 |
| 15 | Ranganath Anil P. See remarks | 2025-06-10 16:44:58 | 13,955 0 | 13,955 | Form 4 |
| 16 | Weill David Director | 2025-05-23 18:41:03 | 12,134 0 | 12,134 | Form 4 |
| 17 | Basile Edward M Director | 2025-05-29 16:30:11 | 11,151 0 | 11,151 | Form 4 |
| 18 | Gunderson Thomas James Director | 2025-05-23 18:45:45 | 4,059 0 | 4,059 | Form 4 |
| 19 | RAINES MERILEE Director | 2025-05-23 18:46:53 | 4,059 0 | 4,059 | Form 4 |
| 20 | Lovell Stephanie Director | 2025-05-23 18:48:01 | 4,059 0 | 4,059 | Form 4 |
| 21 | Gilbert James Director | 2019-05-01 19:06:22 | 0 0 | 0 | Form 3 |
| 22 | UNITED THERAPEUTICS Corp Lung Biotechnology PBC 10% Owner | 2021-02-05 06:04:18 | 0 0 | 0 | Form 13G |